REQUEST A DEMO
Total
USD $0.00
Search more companies

Level Biotechnology Inc. (Taiwan, China)

Main Activities: Machinery, Equipment, and Supplies Merchant Wholesalers | Drugs and Druggists' Sundries Merchant Wholesalers | Research and Development in the Physical, Engineering, and Life Sciences
Full name: Level Biotechnology Inc. Profile Updated: June 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Level Biotechnology Inc. was established in December 1989. Formerly known as Advanced Technology, in 1989 it changed its name to A Level Biotechnology. Public offering was issued in June 2001. The main business is divided into biomedical products and pre-clinical trials. Its revenue sources from consuming material fostering, antibody reagents, and instruments and equipments. The domestic-based sales channels are the major research institutions. And its customers are Corning organisms, Academia Sinica, Jin-order technology, National Taiwan University hospitals and etc. Sources of technology: A. This Company opposes the chimerical transgenic technology transferred from Academia Sinica. B. It also has protein-protein interaction technology trough technology transfer from National Institutes of Health study of. C. The company takes exclusively of transgenic mice market in Taiwan. D. The company cooperates with Animal Center of National Taiwan University on the raw materials in mice.

Headquarters
No.80,Lane 169, Kang Ning St., Hsi-Chih
New Taipei City; New Taipei City;

Contact Details: Purchase the Level Biotechnology Inc. report to view the information.

Website: http://www.level.com.tw

Basic Information
Total Employees:
Purchase the Level Biotechnology Inc. report to view the information.
Outstanding Shares:
Purchase the Level Biotechnology Inc. report to view the information.
Financial Auditors:
Purchase the Level Biotechnology Inc. report to view the information.
Incorporation Date:
December 07, 1989
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
4%
Purchase this report to view the information.
3.33%
Purchase this report to view the information.
3.08%
Purchase this report to view the information.
2.48%
Purchase this report to view the information.
2.31%
Subsidiaries
Horien Biochemical Technology Co., Ltd.
0.82%
Hwa Hsying Biotechnology Co., Ltd.
0.01%
Company Performance
Financial values in the chart are available after Level Biotechnology Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
11.77%
Total operating revenue
10.74%
Operating profit (EBIT)
3.79%
EBITDA
5.41%
Net Profit (Loss) for the Period
5.95%
Total assets
0.88%
Total equity
1.81%
Operating Profit Margin (ROS)
-0.77%
Net Profit Margin
-0.48%
Return on Equity (ROE)
0.32%
Debt to Equity Ratio
-0.14%
Quick Ratio
-0.05%
Cash Ratio
-0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?